Intelligent Bio Solutions Inc. (INBS) Asset Writedowns and Impairment (2022 - 2024)

Intelligent Bio Solutions' Asset Writedowns and Impairment history runs 3 years deep, the most recent figure standing at $263.0 for Q1 2024.

• In Q1 2024, Asset Writedowns and Impairment changed N/A year-over-year to $263.0; the TTM figure through Mar 2024 stood at $72115.0 (changed N/A YoY), while the FY2025 annual figure was $220062.0, changed N/A from the prior year.
• Asset Writedowns and Impairment for Q1 2024 stood at $263.0, down from $1165.0 in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $67851.0 in Q3 2023, with the low at $263.0 in Q1 2024.
• The 3-year median for Asset Writedowns and Impairment is $2836.0 (2023), against an average of $19006.6.
• Peak annual rise in Asset Writedowns and Impairment reached 94.92% in 2023, while the deepest fall reached 94.92% in 2023.
• Intelligent Bio Solutions' Asset Writedowns and Impairment stood at $22918.0 in 2022, then plunged by 94.92% to $1165.0 in 2023, then tumbled by 77.42% to $263.0 in 2024.
• Business Quant data shows INBS's Asset Writedowns and Impairment at $263.0 in Q1 2024, $1165.0 in Q4 2023, and $67851.0 in Q3 2023.